Search

everythinglearnresearchcommunity

for

Search:↓

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

ESR2 gene variations may be linked to female pattern hair loss.

Aromatase gene variation may increase female hair loss risk.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Longer CAG repeats in gene linked to more severe hair loss in females.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

No link found between aromatase gene and female hair loss.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Parsley contains compounds that might be good for treating hair loss.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Mice with human gene experienced hair loss when treated with DHT.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.